Sudo Biosciences Alternatives & Competitors
12 companies similar to Sudo Biosciences — Developing precision TYK2 therapeutics.
Companies similar to Sudo Biosciences
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
Cambridge, United States
ACELYRIN, INC.
We are a late-stage clinical biopharma company focused on providing life-changing new trea...
Agoura Hills, United Stat...
Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegene...
Cambridge, United States
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
Track all Sudo Biosciences competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
South San Francisco, Unit...
Zenas BioPharma
Enabling patients with autoimmune diseases to reimagine life
Waltham, United States
Novoron Bioscience
Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the...
San Diego, United States
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
Pharvaris
Pioneering science for patient choice
Zug, Switzerland
Alterome Therapeutics, Inc
To Life!
San Diego, United States
About Sudo Biosciences
Sudo Biosciences, founded in 2020 and headquartered in the United States, is a burgeoning force in the biopharmaceutical sector. With a focused mission encapsulated by its slogan, "Developing precision TYK2 therapeutics," the company is committed to delivering innovative, best-in-class medicines aimed at transforming p...
Development of first and best-in-class medicines, Therapies for neurological and immunological diseases, Drug design and optimization, Clinical trial management
Patients with serious neurological conditions, Patients with immune-mediated inflammatory conditions, Healthcare providers and institutions
Biopharmaceutical, Precision Therapeutics, TYK2 Pseudokinase Domain, Cytokine Signaling, Immune-Mediated Inflammatory Conditions, Multiple Sclerosis, Neurodegenerative Diseases, Brain-Penetrant Therapeutics, Neuroinflammation, Topical Candidate, Dermatologic Diseases, Next-Generation Inhibitors, Drug Development, Novel Medicines, Patient-Centric Healthcare
B2B, B2C, B2D
Licensing, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Sudo Biosciences and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Sudo Biosciences on 9 Jun 2026. The 12 companies listed here were last checked between 7 Jun 2025 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
